Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$17.2M Buy
59,100
+30,600
+107% +$8.6M 0.07% 259
2018
Q1
$7.8M Buy
28,500
+22,500
+375% +$6.98M 0.03% 576
2017
Q4
$1.91M Sell
6,000
-52,900
-90% -$17M 0.01% 1438
2017
Q3
$18.4M Sell
58,900
-1,100
-2% -$326K 0.09% 221
2017
Q2
$16.3M Buy
60,000
+36,100
+151% +$9.55M 0.09% 214
2017
Q1
$6.54M Sell
23,900
-57,300
-71% -$16.2M 0.05% 444
2016
Q4
$23M Sell
81,200
-2,000
-2% -$593K 0.16% 103
2016
Q3
$26M Buy
83,200
+34,500
+71% +$10.2M 0.19% 79
2016
Q2
$11.8M Sell
48,700
-25,800
-35% -$6.8M 0.09% 263
2016
Q1
$19.4M Buy
74,500
+36,800
+98% +$9.72M 0.16% 131
2015
Q4
$11.5M Buy
37,700
+6,400
+20% +$1.84M 0.08% 317
2015
Q3
$9.13M Sell
31,300
-11,100
-26% -$3.67M 0.05% 519
2015
Q2
$17.1M Sell
42,400
-5,600
-12% -$2.25M 0.1% 227
2015
Q1
$20.3M Buy
48,000
+21,300
+80% +$8.4M 0.15% 118
2014
Q4
$9.06M Sell
26,700
-29,200
-52% -$9.45M 0.07% 356
2014
Q3
$18.5M Sell
55,900
-28,700
-34% -$9.46M 0.14% 143
2014
Q2
$26.7M Buy
84,600
+24,400
+41% +$7.34M 0.25% 48
2014
Q1
$18.4M Buy
60,200
+16,000
+36% +$5.08M 0.16% 98
2013
Q4
$12.4M Sell
44,200
-44,200
-50% -$11.4M 0.09% 244
2013
Q3
$10.7M Buy
88,400
+67,800
+329% +$15.2M 0.07% 304
2013
Q2
$4.43K Buy
+20,600
New +$4.4M 0.02% 849

Other funds holding BIIB

PEAK6 Group's BIIB Position: Q2 2018 in Review

PEAK6 Group sold out of Biogen (BIIB) in Q2 2018, closing a stake of 24,081 shares — an estimated $6.77M sold.

PEAK6 Group first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $34M in Q4 2014. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • PEAK6 Group reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,081 Biogen shares in Q2 2018, an estimated $6.77M.
  • PEAK6 Group first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • PEAK6 Group's Biogen position peaked at $34M in Q4 2014.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.